Brief: Inmed Pharmaceuticals' Inm-901 Demonstrates Unique Pharmacological Effects In Alzheimer's Disease In Preclinical Proof-Of-Concept Studies

InMed Pharmaceuticals

24/10/2023 22:06

Oct 24 (Reuters) - InMed Pharmaceuticals Inc  INM.O :
    * INMED PHARMACEUTICALS INC. S INM-901 DEMONSTRATES UNIQUE
PHARMACOLOGICAL EFFECTS IN ALZHEIMER S DISEASE IN PRECLINICAL
PROOF-OF-CONCEPT STUDIES
    * INMED PHARMACEUTICALS INC - IN VITRO ALZHEIMER S DISEASE
STUDIES
SHOW THAT INM-901 TREATED GROUPS DISPLAY NEUROPROTECTION AND
EXTENDED NEURITE LENGTH
    * INMED PHARMACEUTICALS INC - INM-901 TREATED GROUPS IN AN
IN VIVO
ALZHEIMER S DISEASE MODEL DEMONSTRATE IMPROVED BEHAVIORAL
    * INMED PHARMACEUTICALS-SELECTED LEAD ALZHEIMER S DISEASE
DRUG
CANDIDATE,NAMED INM-901,FOLLOWING POSITIVE RESULTS FROM SEVERAL
PROOF-OF-CONCEPT STUDIES

Further company coverage:  INM.O 

 ((reuters.briefs@thomsonreuters.com;))